DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression
Authors
Keywords
DLX6-AS1, lncRNAs, miRNA, Cancer biomarkers, Therapeutic targets
Journal
CLINICA CHIMICA ACTA
Volume 517, Issue -, Pages 1-8
Publisher
Elsevier BV
Online
2021-02-17
DOI
10.1016/j.cca.2021.02.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long Noncoding RNA DLX6-AS1 Promotes the Progression in Cervical Cancer by Targeting miR-16-5p/ARPP19 Axis
- (2020) Fangfang Xie et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- The role of long noncoding RNAs in hepatocellular carcinoma
- (2020) Zhao Huang et al. Molecular Cancer
- Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
- (2020) Li Yuan et al. Molecular Cancer
- Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells
- (2020) Asma Vafadar et al. Cell and Bioscience
- PIWI-interacting RNAs: new biomarkers for diagnosis and treatment of breast cancer
- (2020) Parisa Maleki Dana et al. Cell and Bioscience
- The functions of long non-coding RNAs in neural stem cell proliferation and differentiation
- (2020) Yanfang Zhao et al. Cell and Bioscience
- lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway
- (2020) Yan Liu et al. Cancer Management and Research
- Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway
- (2020) Hengbing Wang et al. Aging-US
- Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury
- (2020) Jixiang Tan et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Pathology of triple negative breast cancer
- (2020) Filippo Borri et al. SEMINARS IN CANCER BIOLOGY
- Emerging roles of long non-coding RNAs in breast cancer biology and management
- (2020) I. Amelio et al. SEMINARS IN CANCER BIOLOGY
- Long non‐coding RNA DLX6‐AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region
- (2020) Hui Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone
- (2020) Shuzhong Liu et al. Journal of Bone Oncology
- Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis
- (2020) Xiaoming Liu et al. CANCER GENE THERAPY
- Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain
- (2019) Xin Pang et al. RNA Biology
- Long noncoding RNA DLX6‐AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR‐424‐5p
- (2019) Dan Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Comprehensive analysis of dysregulated lncRNAs, miRNAs and mRNAs with associated ceRNA network in esophageal squamous cell carcinoma
- (2019) Wenze Tian et al. GENE
- Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells
- (2019) Fei Chen et al. NATURE CELL BIOLOGY
- Cellular functions of long noncoding RNAs
- (2019) Run-Wen Yao et al. NATURE CELL BIOLOGY
- Long non-coding RNAs in genitourinary malignancies: a whole new world
- (2019) Ronan Flippot et al. Nature Reviews Urology
- LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis
- (2019) Wen Sun et al. OncoTargets and Therapy
- Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/ FZD6/Wnt/β-catenin pathway in pancreatic cancer
- (2019) Jiyong Yang et al. Cancer Management and Research
- Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells
- (2019) Dong-Mei Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1
- (2019) Qiong Wu et al. CANCER BIOLOGY & THERAPY
- Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis
- (2019) Chen Fang et al. CELL CYCLE
- Long non-coding RNA in lung cancer
- (2019) Zhenyao Chen et al. CLINICA CHIMICA ACTA
- The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
- (2019) Ling Wei et al. Molecular Cancer
- c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
- (2019) Wen Jing Sim et al. Nature Communications
- Functional Classification and Experimental Dissection of Long Noncoding RNAs
- (2018) Florian Kopp et al. CELL
- Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer
- (2018) Yujiao Xie et al. Molecular Oncology
- Ewing sarcoma
- (2018) Thomas G. P. Grünewald et al. Nature Reviews Disease Primers
- Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis
- (2018) Yan Tan et al. EXPERIMENTAL CELL RESEARCH
- LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling
- (2018) Rong-mou Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer
- (2018) Yongjie Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531
- (2018) Clare J. Twist et al. JOURNAL OF CLINICAL ONCOLOGY
- Racial Disparity in Gastrointestinal Cancer Risk
- (2017) Hassan Ashktorab et al. GASTROENTEROLOGY
- Drugging DNA repair to target T-ALL cells
- (2017) Yashodhara Dasgupta et al. LEUKEMIA & LYMPHOMA
- Dysregulated expression of long noncoding RNAs in gynecologic cancers
- (2017) Elahe Seyed Hosseini et al. Molecular Cancer
- Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
- (2017) Xiaoqi Huo et al. Molecular Cancer
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors
- (2017) Alex Martin-Trujillo et al. Nature Communications
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
- (2015) Michael S. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- The emerging role of lncRNAs in cancer
- (2015) Maite Huarte NATURE MEDICINE
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- Gadd45a deletion aggravates hematopoietic stem cell dysfunction in ATM-deficient mice
- (2014) Yulin Chen et al. Protein & Cell
- Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses
- (2011) M. N. Cabili et al. GENES & DEVELOPMENT
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started